4//SEC Filing
Glickman Mark A 4
Accession 0001104659-24-069785
CIK 0001638287other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:25 PM ET
Size
5.4 KB
Accession
0001104659-24-069785
Insider Transaction Report
Form 4
Glickman Mark A
Director
Transactions
- Award
Common Stock
2024-06-07+5,051→ 9,740 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date.
- [F2]The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001441461
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 7:25 PM ET
- Size
- 5.4 KB